Inactive Instrument

Highlights Nexus BioPharma, Inc.

Equities

Nexus BioPharma, Inc. to License TransChem's Transition State Chemistry Technology for Kinase Inhibition	10/16/10	CI
Nexus Seeks Acquisition	28/16/28	CI
Nexus BioPharma Corporation completed the acquisition of Nexus BioPharma, Inc. in a reverse merger transaction.	09/16/09	CI
Nexus BioPharma Corporation entered into an agreement of merger and plan of reorganization to acquire Nexus BioPharma, Inc. in a reverse merger transaction.	19/16/19	CI

No results for this search